Treatment of pemphigus vulgaris with anti-CD20 monoclonal antibody (rituximab)
- 1 March 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 148 (3) , 602-603
- https://doi.org/10.1046/j.1365-2133.2003.05209_10.x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Plasma cells for a lifetime?European Journal of Immunology, 2002
- Pathophysiology and Therapy of Pemphigus in the 21st CenturyThe Journal of Dermatology, 2001
- Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLLAmerican Journal of Hematology, 2001
- Immunoablative high-dose cyclophosphamide without stem cell rescue in a patient with pemphigus vulgarisJournal of the American Academy of Dermatology, 2000
- Free recirculation of memory B cells versus antigen-dependent differentiation to antibody-forming cells.The Journal of Immunology, 1994